Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004035477 | SCV002755580 | uncertain significance | not specified | 2020-08-26 | criteria provided, single submitter | clinical testing | The p.V381M variant (also known as c.1141G>A), located in coding exon 10 of the IKBKAP gene, results from a G to A substitution at nucleotide position 1141. The valine at codon 381 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is poorly conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV002480905 | SCV002776254 | uncertain significance | Medulloblastoma; Familial dysautonomia | 2022-03-31 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV004692394 | SCV005195522 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001278726 | SCV001465758 | uncertain significance | Familial dysautonomia | 2020-08-19 | no assertion criteria provided | clinical testing |